Dimethyl fumarate for relapsing-remitting multiple sclerosis

Dimethyl fumarate is the third oral disease-modifying treatment for people with RRMS. Steve Chaplin presents the data relating to its efficacy and adverse events and Klaus Schmierer outlines its place in therapy.

Dimethyl fumarate for relapsing remitting multiple sclerosis

Add yours ↓
Web design and marketing agency Leamington Spa